[DEBUG-WINDOW 처리영역 보기]
회원가입    로그인
배너1 배너2 스폰서배너광고 안내
오늘의 BRIC정보
트위터 페이스북
검색 뉴스레터 안내
좋은 연구문화 만들기
검색어 자동완성
통합검색 동향검색 한빛사검색 Bio일정검색 VOD검색 실험검색 Bio마켓검색 BioJob검색 커뮤니티검색 농수식품검색 생물종검색 외부 협력검색
남기훈(한국과학기술연구원, 고려대학교)
이은정(한국과학기술연구원, 경북대학교)
박승윤(한국과학기술연구원, 동국대학교 의과대학)
김인산(한국과학기술연구원, 고려대학교)
Combined Rho-kinase inhibition and immunogenic cell death triggers and propagates immunity against cancer
Nat. Commun., Published:04 June 2018, 9, Article number: 2165 | doi:10.1038/s41467-018-04607-9
Cancer Biology/Oncology
강단비(성균관대학교 의과대학, 삼성서울병원, 성균관대학교)
조주희(성균관대학교 의과대학, 삼성서울병원, 성균관대학교, Johns Hop..)
Incidence of Diabetes After Cancer Development : A Korean National Cohort Study
JAMA Oncol., Published online June 7, 2018 | doi:10.1001/jamaoncol.2018.1684
Cancer Biology/Oncology
조진현(인하대학교 의과대학, 인하대학교병원)
안명주(성균관대학교 의과대학, 삼성서울병원)
Pembrolizumab for Patients With Refractory or Relapsed Thymic Epithelial Tumor: An Open-Label Phase II Trial
J. Clin. Oncol., Published online before print June 15, 2018 | https://doi.org/10.1200/JCO.2017.77.3184
Cancer Biology/Oncology
오상철(The University of Texas MD Anderson Cancer Center, 고려대학..)
손보화(The University of Texas MD Anderson Cancer Center)
정재호(연세대학교 의과대학)
김상배(The University of Texas MD Anderson Cancer Center)
이주석(The University of Texas M. D. Anderson Cancer Center)
Clinical and genomic landscape of gastric cancer with a mesenchymal phenotype
Nat. Commun., Published:03 May 2018, 9, Article number: 1777 | doi:10.1038/s41467-018-04179-8
Genomics, Cancer Biology/Oncology,
이호준(Genentech Inc.)
Ras–MEK Signaling Mediates a Critical Chk1-Dependent DNA Damage Response in Cancer Cells
Mol. Cancer Ther., April 1 2017 16 (4) 694-704; DOI:10.1158/1535-7163.MCT-16-0504
Cancer Biology/Oncology, Medicine,
안수민(이화여자대학교 의과대학)
김태혁(성균관대학교 의과대학, 삼성서울병원)
오영륜(성균관대학교 의과대학, 삼성서울병원)
정재훈(성균관대학교 의과대학, 삼성서울병원)
Comprehensive screening for PD-L1 expression in thyroid cancer
Endocr.-Relat. Cancer, February 1, 2017, 24 97-106, doi: 10.1530/ERC-16-0421
Cancer Biology/Oncology
황지은(University of Sydney)
Bullous pemphigoid, an autoantibody-mediated disease, is a novel immune-related adverse event in patients treated with anti-programmed cell death 1 antibodies
Melanoma Res., 2016 Aug;26(4):413-416.
Cancer Biology/Oncology, Medicine,
한경석(연세대학교 의과대학, University of British Columbia)
Inhibition of endoplasmic reticulum chaperone protein glucose-regulated protein 78 potentiates anti-angiogenic therapy in renal cell carcinoma through inactivation of the PERK/eIF2α pathway
Oncotarget, Published: October 12, 2015; 6:34818-34830 | https://doi.org/10.18632/oncotarget.5397
Cancer Biology/Oncology, Cell_Biology,
Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2013
Cancer Res. Treat., Published online: March 3, 2016, 48(2): 436-450. | DOI: https://doi.org/10.4143/crt.2016.089
Medicine, Cancer Biology/Oncology,
Byoung S. Kwon(국립암센터, Tulane University Health Sciences Center)
Immune evasion in cancer: Mechanistic basis and therapeutic strategies
Semin. Cancer Biol., Volume 35, Supplement, December 2015, Pages S185-S198 | https://doi.org/10.1016/j.semcancer.2015.03.004
Cancer Biology/Oncology, Immunology,
박세훈(성균관대학교 삼성의료원)
손태성(성균관대학교 의과대학)
Phase III Trial to Compare Adjuvant Chemotherapy With Capecitabine and Cisplatin Versus Concurrent Chemoradiotherapy in Gastric Cancer: Final Report of the Adjuvant Chemoradiotherapy in Stomach Tumors Trial, Including Survival and Subset Analyses
J Clin Oncol, 33, no. 28 (October 2015) 3130-3136 | DOI: 10.1200/JCO.2014.58.3930
Cancer Biology/Oncology, Medicine,
방영주(서울대학교 의과대학)
Randomized, Double-Blind Phase II Trial With Prospective Classification by ATM Protein Level to Evaluate the Efficacy and Tolerability of Olaparib Plus Paclitaxel in Patients With Recurrent or Metastatic Gastric Cancer
J. Clin. Oncol., Published online before print August 17, 2015 | doi: 10.1200/JCO.2014.60.0320
Cancer Biology/Oncology
이정원(D. Anderson Cancer Center, 현재 성균관대학교 ...) 
EphA2 Immunoconjugate as Molecularly Targeted Chemotherapy for Ovarian Carcinoma
2009.08.07 | J. Natl. Cancer Inst.
김현재(Memorial Sloan Kettering Cancer Center) 
Prospective Comprehensive Molecular Characterization of Lung Adenocarcinomas for Efficient Patient Matching to Approved and Emerging Therapies
2017.04.14 | Cancer Discov.
신상훈(University of California, Los Angeles) 
Primary Resistance to PD-1 Blockade Mediated by JAK½ Mutations
2016.12.14 | Cancer Discov.
김상범(University of Texas Southwestern Medical Center) 
Targeting of Nrf2 induces DNA damage signaling and protects colonic epithelial cells from ionizing radiation
2012.10.18 | Proc. Natl. Acad. Sci. USA
검색광고 안내
맨위로 가기

BRIC 홈    BRIC 소개    회원    검색    문의/FAQ    광고
Copyright © BRIC. All rights reserved. Contact member@ibric.org